Search research articles
Contact Us
Filters
Showing results (51-60 of 87) with videos related to
Page
of 9
Sort By:
Experimental and Therapeutic Medicine
|
February 15, 2013
Opposite effect of angiotensin receptor blockade on CXCL8 production and CXCR1/2 expression of angiotensin II-treated THP-1 monocytes
Konstantina Vogiatzi, Stavros Apostolakis, Zaharenia Vlata, et al.
Chest
|
September 7, 2013
Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study
Gregory Y H Lip, Deirdre A Lane, Harry Buller, et al.
Chest
|
May 15, 2013
Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score
Stavros Apostolakis, Renee M Sullivan, Brian Olshansky, et al.
The Pediatric Infectious Disease Journal
|
April 29, 2006
T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis
Virginia Amanatidou, George Sourvinos, Stavros Apostolakis, et al.
Clinical Therapeutics
|
August 23, 2014
The impact of heart failure and left ventricular dysfunction in predicting stroke, thromboembolism, and mortality in atrial fibrillation patients: a systematic review
Megha Agarwal, Stavros Apostolakis, Deirdre A Lane, et al.
Chest
|
February 5, 2014
Response
Stavros Apostolakis, Renee M Sullivan, Brian Olshansky, et al.
Journal of Thrombosis and Thrombolysis
|
November 17, 2009
Angiotensin II up-regulates CX3CR1 expression in THP-1 monocytes: impact on vascular inflammation and atherogenesis
Stavros Apostolakis, Zacharenia Vlata, Konstantina Vogiatzi, et al.
Chest
|
January 8, 2014
Response
Stavros Apostolakis, Renee M Sullivan, Brian Olshansky, et al.
Stroke
|
September 6, 2014
Hormone replacement therapy and adverse outcomes in women with atrial fibrillation: an analysis from the atrial fibrillation follow-up investigation of rhythm management trial
Stavros Apostolakis, Renee M Sullivan, Brian Olshansky, et al.
Thrombosis and Haemostasis
|
November 6, 2009
Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation"
Stavros Apostolakis, Eduard Shantsila, Gregory Y H Lip, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 87) with videos related to
Sort By:
Page
of 9
Experimental and Therapeutic Medicine
|
February 15, 2013
Opposite effect of angiotensin receptor blockade on CXCL8 production and CXCR1/2 expression of angiotensin II-treated THP-1 monocytes
Konstantina Vogiatzi, Stavros Apostolakis, Zaharenia Vlata, et al.
Chest
|
September 7, 2013
Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study
Gregory Y H Lip, Deirdre A Lane, Harry Buller, et al.
Chest
|
May 15, 2013
Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score
Stavros Apostolakis, Renee M Sullivan, Brian Olshansky, et al.
The Pediatric Infectious Disease Journal
|
April 29, 2006
T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis
Virginia Amanatidou, George Sourvinos, Stavros Apostolakis, et al.
Clinical Therapeutics
|
August 23, 2014
The impact of heart failure and left ventricular dysfunction in predicting stroke, thromboembolism, and mortality in atrial fibrillation patients: a systematic review
Megha Agarwal, Stavros Apostolakis, Deirdre A Lane, et al.
Chest
|
February 5, 2014
Response
Stavros Apostolakis, Renee M Sullivan, Brian Olshansky, et al.
Journal of Thrombosis and Thrombolysis
|
November 17, 2009
Angiotensin II up-regulates CX3CR1 expression in THP-1 monocytes: impact on vascular inflammation and atherogenesis
Stavros Apostolakis, Zacharenia Vlata, Konstantina Vogiatzi, et al.
Chest
|
January 8, 2014
Response
Stavros Apostolakis, Renee M Sullivan, Brian Olshansky, et al.
Stroke
|
September 6, 2014
Hormone replacement therapy and adverse outcomes in women with atrial fibrillation: an analysis from the atrial fibrillation follow-up investigation of rhythm management trial
Stavros Apostolakis, Renee M Sullivan, Brian Olshansky, et al.
Thrombosis and Haemostasis
|
November 6, 2009
Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation"
Stavros Apostolakis, Eduard Shantsila, Gregory Y H Lip, et al.
Page
of 9